论文部分内容阅读
阿糖胞甙(Ara—C)与6-硫代鸟便嘌呤(6-TG)联合治疗是近来用于急粒诱导缓解的有效方案,已有文献报告。本文作者对晚期难治性急淋的儿童,采用Ara—C与6-TG联合治疗,取得一定的疗效,完全缓解率达47%。 19例急淋儿童.女9例,男10例,年龄1~16岁,接受抗白血病药物平均年限为2年,所有病例在难治以前用过强的松,长春新硷、6MP、氨甲喋呤、红卫霉素和门冬酰胺酶,但无一例用过Ara-C。
Ara-C (Ara-C) and 6-thiogenin purine (6-TG) combination therapy is an effective regimen for acute pellet induction and has been reported in the literature. The author of advanced refractory acute lymphocytic children, using Ara-C and 6-TG combination therapy, and achieved a certain effect, the complete remission rate of 47%. 19 cases of acute lymphoblastic children, 9 females, 10 males, aged 1 to 16 years old, the average age of anti-leukemia drugs received 2 years, all cases of prednisone, vincristine, 6MP, methotrexate, Rhodomycin and Asparaginase, but no Ara-C was used.